Literature DB >> 18048473

The role of exercise training in peripheral arterial disease.

Richard V Milani1, Carl J Lavie.   

Abstract

Peripheral arterial disease (PAD) is currently a major health problem affecting 8-12 million Americans, 15-40% of whom will have intermittent claudication that can lead to substantial impairment in their ability to carry out normal daily activities as well as perform the recommended cardiovascular exercise. Supervised exercise training is an effective tool in the treatment of claudication and is currently a recommended first-line therapy for patients with this condition. In addition to improving pain-free walking distance and quality of life, supervised exercise training can improve many cardiovascular risk factors, possibly reducing the risk for subsequent myocardial infarction, stroke, and death. This paper will review the benefits of supervised exercise training in patients with PAD.

Entities:  

Mesh:

Year:  2007        PMID: 18048473     DOI: 10.1177/1358863X07083177

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  14 in total

1.  Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training.

Authors:  Jessica C Taylor; H T Yang; M Harold Laughlin; Ronald L Terjung
Journal:  J Physiol       Date:  2008-11-03       Impact factor: 5.182

2.  Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling.

Authors:  Johnathon D Anderson; Henrik J Johansson; Calvin S Graham; Mattias Vesterlund; Missy T Pham; Charles S Bramlett; Elizabeth N Montgomery; Matt S Mellema; Renee L Bardini; Zelenia Contreras; Madeline Hoon; Gerhard Bauer; Kyle D Fink; Brian Fury; Kyle J Hendrix; Frederic Chedin; Samir El-Andaloussi; Billie Hwang; Michael S Mulligan; Janne Lehtiö; Jan A Nolta
Journal:  Stem Cells       Date:  2016-02-19       Impact factor: 6.277

3.  Clot strength is negatively associated with ambulatory function in patients with peripheral artery disease and intermittent claudication.

Authors:  Karin Mauer; Andrew W Gardner; Tarun W Dasari; Julie A Stoner; Steve M Blevins; Polly S Montgomery; Jorge F Saucedo; J Emilio Exaire
Journal:  Angiology       Date:  2014-04-27       Impact factor: 3.619

Review 4.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

5.  Impaired Coronary Endothelial Vasorelaxation in a Preclinical Model of Peripheral Arterial Insufficiency.

Authors:  A A Arce-Esquivel; A K Bunker; G H Simmons; H T Yang; M H Laughlin; R L Terjung
Journal:  J Heart Cardiol       Date:  2015-06-29

6.  The Impact of Walking Exercises and Resistance Training upon the Walking Distance in Patients with Chronic Lower Limb Ischaemia.

Authors:  Maria Szymczak; Grzegorz Oszkinis; Marian Majchrzycki
Journal:  Biomed Res Int       Date:  2016-10-19       Impact factor: 3.411

Review 7.  Safety and efficacy of cilostazol in the management of intermittent claudication.

Authors:  Yung-Wei Chi; Carl J Lavie; Richard V Milani; Christopher J White
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: a randomized clinical trial.

Authors:  Edita Jakubsevičienė; Donatas Vasiliauskas; Linas Velička; Raimondas Kubilius; Eglė Milinavičienė; Jonė Venclovienė
Journal:  Int J Environ Res Public Health       Date:  2014-08-07       Impact factor: 3.390

9.  Combined Dietary Nitrate and Exercise Intervention in Peripheral Artery Disease: Protocol Rationale and Design.

Authors:  Mary N Woessner; Mitch D VanBruggen; Carl F Pieper; Erin K O'Reilly; William E Kraus; Jason D Allen
Journal:  JMIR Res Protoc       Date:  2017-10-03

Review 10.  Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects.

Authors:  Sebastian Steven; Andreas Daiber; Jörn F Dopheide; Thomas Münzel; Christine Espinola-Klein
Journal:  Redox Biol       Date:  2017-04-13       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.